RESISTELL AG
RESISTELL AG
Industry:
Medical Device
Founded:
2018-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Total Employee:
1+
Status:
Active
Contact:
+41 79 899 91 88
Total Funding:
7.32 M USD
Similar Organizations
Clemedi
Clemedi provides antibiotic resistance testing.
Dxcover
The Future of Cancer Diagnostics
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
Seno Medical Instruments
Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Pfizer
Pfizer investment in Grant - Resistell AG
European Innovation Council
European Innovation Council investment in Grant - Resistell AG
OCCIDENT
OCCIDENT investment in Series A - Resistell AG
Alpana Ventures
Alpana Ventures investment in Series A - Resistell AG
Hemex
Hemex investment in Series A - Resistell AG
TRUMPF Venture
TRUMPF Venture investment in Series A - Resistell AG
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series A - Resistell AG
OCCIDENT
OCCIDENT investment in Seed Round - Resistell AG
Hemex
Hemex investment in Seed Round - Resistell AG
Venture Kick
Venture Kick investment in Seed Round - Resistell AG
Newest Events participated
More informations about "Resistell AG"
Resistell AG - Crunchbase Company Profile & Funding
Resistell AG closed its last funding round on Dec 19, 2022 from a Series B round. Who are Resistell AG 's competitors? Alternatives and possible competitors to Resistell AG may include …See details»
Resistell 2025 Company Profile: Valuation, Funding & Investors
Resistell was founded in 2017. Where is Resistell headquartered? Resistell is headquartered in Muttenz, Switzerland. What is the size of Resistell? Resistell has 25 total employees. What …See details»
Resistell | EuroQuity
Resistell AG is a deep-tech start-up incorporated in 2018 in Basel region. It is developing the world's fastest Antibiotic Susceptibility Test (AST) based ... Resistell has a very strong cross …See details»
Resistell AG - Funding, Financials, Valuation & Investors
Series A - Resistell AG — OCCIDENT . Yes: Series A - Resistell AG — Alpana Ventures . No: Series A - Resistell AG — Hemex . No: Series A - Resistell AG — Show More . Browse By: …See details»
Resistell AG - Swiss Biotech
Resistell proposes an alternative to culture based antibiogram, the current gold standard in antibiotic susceptibility testing. Our offering is a diagnostic device. The rapid AST is based on …See details»
News: Investors give Resistell 8.5 million Swiss francs
Dec 23, 2022 Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology company plans to use this to gain European certification for its test device, which uses nanotechnology to …See details»
Resistell AG closes its series B first tranche of CHF 8.5m
Dec 19, 2022 Resistell AG, a leader in phenotypic nanomotion technology for measuring living cells, has taken another major step to achieving its vision by closing a first tranche of its series B financing round raising CHF8.5M from …See details»
Resistell Closes Seed Round to Develop Faster Antibiotic Tests
Jul 12, 2018 Resistell AG, a Swiss startup developing a faster tool to identify which antibiotics will treat infections best, raised 750,000 Swiss francs to fund pre-clinical testing. ...See details»
Resistell AG - VentureRadar
We save lives by finding the right antibiotic on time and reduce spreading of antibiotic resistance. Resistell proposes an alternative to culture based antibiogram, the current gold standard in …See details»
Resistell AG closes its series B first tranche of CHF 8.5 …
Dec 23, 2024 Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered. Skip to content. Bio Alps. FIND A HEALTH VALLEY ACTOR Menu. ... Resistell AG …See details»
Resistell AG - developing leading Rapid AST solution
Resistell, an EPFL spin-off developing rapid phenotypic antibiotic susceptibility testing (AST) solutions, announces the peer-reviewed article in the Nature Communications journal. The …See details»
Resistell - Overview, News & Competitors | ZoomInfo.com
Resistell AG closed a first tranche of its Series B financing round with CHF 8.5 million raised from new and existing investors. The Venture Kick and Venture Leader alumn, which was also …See details»
Resistell raises CHF 8.5 million to complete clinical trials for ...
Dec 19, 2022 Resistell AG closed a first tranche of its Series B financing round with CHF 8.5 million raised from new and existing investors. The Venture Kick and Venture Leader alumn, …See details»
Resistell AG announces start of Performance Evaluation Study
Jun 16, 2021 Resistell AG, the start-up developing the world’s fastest phenotypic Antibiotic Susceptibility Test (AST), has started the Performance Evaluation Study (PES) of its …See details»
Resistell raises CHF 8.5 million to complete clinical trials for ...
Dec 22, 2022 Resistell AG closed a first tranche of its Series B financing round with CHF 8.5 million raised from new and existing investors. The startup is a leader in phenotypic …See details»
Medtech Startup Resistell Raises CHF 3.5 Million to Certify its …
Dec 17, 2019 Resistell AG, the Swiss startup developing the world's fastest phenotypic antibiotic susceptibility test, will use the funding to achieve CE-mark approval for its first device testing …See details»
Resistell AG - DevelopmentAid
Resistell AG — Supplier from Switzerland with 2-10 employees, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Laboratory & Measurement sectors. Our website …See details»
Resistell initiates a research project funded by an independent …
Apr 20, 2022 Resistell, a TOP10 Swiss Start-up addressing the problem of speed in the diagnostics of antibiotic resistance, is pleased to announce they have initiated a research …See details»
Resistell Raises CHF 3.5 Million to Certify its Blood Infection …
Dec 17, 2019 Resistell AG, the Swiss startup developing the world's fastest phenotypic antibiotic susceptibility test, will use the funding to achieve CE-mark approval for its first device testing …See details»
2025 AgriStability and AgriInvest Program – Corporation/Co …
Feb 28, 2025 Agriculture Financial Services Corporation 5718-56th Avenue Lacombe AB T4L 1B1 Toll-free telephone: 1-877-899-2372 Toll-free fax: 1-855-700-2372 Email: [email protected] …See details»